Major pharmaceutical companies have agreed to cap out-of-pocket costs for some asthma patients at $35 per month, a move that offers relief but doesn’t fully address the larger issue of high drug costs.Patient Kenny Mendez said an asthma attack is “like breathing through a straw.””You’re…
[ad_2]
Source link
